Clinical Trial Update: Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Vudalimab in locally advanced or metastatic anaplastic thyroid carcinoma and oncocytic (Hurthle cell) thyroid carcinoma. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Oncocytic Thyroid Carcinoma

Drugs mentioned

• Vudalimab (XmAb20717)

Snippet

Sponsor: Northwestern University | Conditions: Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING